Aberrant DNMTs Promote TXNIP Upregulation and Ovarian Fibrosis in PCOS
The FASEB Journal · 15.04.2026 · 40 (7)
DOI: 10.1096/fj.202505030r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 04.04.2026. Verfasst von Yajing Weng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing Universit…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Carrier Proteins, Ovary, DNA (Cytosine-5-)-Methyltransferases. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Shanghai Municipal Health Commission (), National Natural Science Foundation of China.
Abstract (Originalsprache)
Hyperandrogenism and elevated thioredoxin‐interacting protein (TXNIP) are potential causes of infertility in women with polycystic ovary syndrome (PCOS). Epigenetic regulation of TXNIP mediates oxidative stress and inflammatory activation. However, the precise mechanisms including epigenetic regulation in PCOS are poorly understood. In this study, aberrant TXNIP in dehydroepiandrosterone (DHEA)‐induced rat PCOS ovaries and dihydrotestosterone (DHT)‐induced PCOS primary granulosa cells (GCs) coincided with a marked increase of DNA methyltransferases (DNMTs); this aberrant TXNIP triggers the release of pro‐fibrotic factors, such as collagen I, α ‐SMA, and TGF‐ β , from GCs. Administration of the DNMT inhibitor 5‐Aza downregulated TXNIP expression and improved the aberrant expression of the pro‐fibrotic factors in PCOS‐like ovaries and DHT‐treated GCs. Furthermore, MG132, a proteasome inhibitor, attenuated the inhibitory effect of 5‐Aza on DHT‐induced TXNIP upregulation. Our data suggest that DNMT activation, by suppressing proteasome activity, contributes to increases in TXNIP expression, resulting in ovarian fibrosis and GC dysfunction in PCOS‐like ovaries after exposure to hyperandrogenism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing, China.
- School of Medicine, Jiaxing University, Jiaxing, China.
- Department of Endocrinology, The Affiliated Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
- Department of Health Technology and Informatics, Hong Kong Polytechnic University, Hong Kong, China.
- Department of Traditional Chinese Medicine, The Affiliated Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
ORCID-Profile: Yong Wang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Shanghai Municipal Health Commission ()
- National Natural Science Foundation of China
Zitieren
APA
Weng, Y., Shangguan, L., Shen, Q., Zhu, Z., Zhang, Y., Zhang, J., Yan, G., Shen, S., Xiang, Z., Ruan, J., Wen, Y., Wang, D., & Wang, Y. (2026). Aberrant DNMTs Promote TXNIP Upregulation and Ovarian Fibrosis in PCOS. The FASEB Journal, 40(7). https://doi.org/10.1096/fj.202505030r
Vancouver
Weng Y, Shangguan L, Shen Q, Zhu Z, Zhang Y, Zhang J, et al. Aberrant DNMTs Promote TXNIP Upregulation and Ovarian Fibrosis in PCOS. The FASEB Journal. 2026;40(7). doi:10.1096/fj.202505030r
BibTeX
@article{Weng2026,
author = {Weng, Yajing and Shangguan, Luxi and Shen, Qi and Zhu, Zhengquan and Zhang, Yaling and Zhang, Jingwen and Yan, Guijun and Shen, Shanmei and Xiang, Zou and Ruan, Jianguo and Wen, Yanting and Wang, Daojuan and Wang, Yong},
title = {Aberrant DNMTs Promote TXNIP Upregulation and Ovarian Fibrosis in PCOS},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {7},
doi = {10.1096/fj.202505030r}
}
EUVIMED